ZA947337B - Use of angiotensin II analogs in tissue repair - Google Patents

Use of angiotensin II analogs in tissue repair

Info

Publication number
ZA947337B
ZA947337B ZA947337A ZA947337A ZA947337B ZA 947337 B ZA947337 B ZA 947337B ZA 947337 A ZA947337 A ZA 947337A ZA 947337 A ZA947337 A ZA 947337A ZA 947337 B ZA947337 B ZA 947337B
Authority
ZA
South Africa
Prior art keywords
analogs
angiotensin
tissue repair
wound healing
compositions
Prior art date
Application number
ZA947337A
Other languages
English (en)
Inventor
Kathleen R Rodgers
Gere Stodder Dizerega
Original Assignee
Univ Southern California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Southern California filed Critical Univ Southern California
Publication of ZA947337B publication Critical patent/ZA947337B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/14—Angiotensins: Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA947337A 1993-09-24 1994-09-21 Use of angiotensin II analogs in tissue repair ZA947337B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12637093A 1993-09-24 1993-09-24

Publications (1)

Publication Number Publication Date
ZA947337B true ZA947337B (en) 1995-05-10

Family

ID=22424466

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA947337A ZA947337B (en) 1993-09-24 1994-09-21 Use of angiotensin II analogs in tissue repair

Country Status (9)

Country Link
US (1) US5716935A (de)
EP (2) EP1333034B1 (de)
JP (1) JPH09503205A (de)
AT (1) ATE473995T1 (de)
AU (1) AU697504B2 (de)
CA (1) CA2172494A1 (de)
DE (1) DE69435301D1 (de)
WO (1) WO1995008565A1 (de)
ZA (1) ZA947337B (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5902790A (en) * 1995-10-03 1999-05-11 Cytran, Inc. Pharmaceutical angiostatic dipeptide compositions and method of use thereof
US5955430A (en) * 1993-09-24 1999-09-21 University Of Southern California Use of angiotensin II fragments and analogs thereof in tissue repair
AU758319B2 (en) * 1994-11-14 2003-03-20 University Of Southern California Use of angiotensin II fragments and analogs thereof in tissue repair
US5834432A (en) 1995-06-06 1998-11-10 The University Of Southern California Use of angiotensin II Type 2 receptor agonists in tissue repair
US6528483B2 (en) 1995-06-07 2003-03-04 André Beaulieu Method of producing concentrated non-buffered solutions of fibronectin
US6110895A (en) * 1996-12-16 2000-08-29 University Of Southern California Method of promoting healing in skin grafts
US6335195B1 (en) 1997-01-28 2002-01-01 Maret Corporation Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
AU6650098A (en) * 1997-02-04 1998-08-25 University Of Southern California Method for accelerating healing of thermal injuries
US6248587B1 (en) 1997-11-26 2001-06-19 University Of Southern Cailfornia Method for promoting mesenchymal stem and lineage-specific cell proliferation
WO1999031125A1 (en) * 1997-12-12 1999-06-24 University Of Southern California Wound healing compositions
CA2319701C (en) 1998-02-09 2009-09-29 University Of Southern California Method of promoting erythropoiesis
US7173011B2 (en) 2000-11-20 2007-02-06 University Of Southern California Radiation therapy methods
JP3728400B2 (ja) * 1998-03-10 2005-12-21 ユニヴァースティ オブ サザーン カリフォルニア 改良型放射線治療の諸方法
US6455500B1 (en) 1998-03-10 2002-09-24 University Of Southern California Radiation therapy methods
US6498138B1 (en) 1998-03-11 2002-12-24 University Of Southern California Method of promoting production of living tissue equivalents
EP1073453B1 (de) * 1998-05-11 2005-04-13 University Of Southern California Verwendung von angiotensin analogen zur herstellung eines arzneimittels zur steigerung des ueberlebens der weissen blutzellen und mobilisierung von haematopoietischen stammzellen nach einer chemotherapeutischen behandlung
US6762167B1 (en) 1998-05-11 2004-07-13 University Of Southern California Methods for treating a patient undergoing chemotherapy
AU756785B2 (en) 1998-07-13 2003-01-23 University Of Southern California Methods for accelerating bone and cartilage growth and repair
US6916783B2 (en) 1998-07-13 2005-07-12 University Of Southern California Methods for accelerating bone and cartilage growth and repair
CA2339330A1 (en) 1998-08-13 2000-02-24 University Of Southern California Methods to increase blood flow to ischemic tissue
AU3734900A (en) * 1999-03-09 2000-09-28 University Of Southern California Method of promoting myocyte proliferation and myocardial tissue repair
US6730775B1 (en) 1999-03-23 2004-05-04 University Of Southern California Methods for limiting scar and adhesion formation
WO2000056345A2 (en) * 1999-03-23 2000-09-28 University Of Southern California Methods for limiting scar and adhesion formation
US7338938B2 (en) 1999-05-10 2008-03-04 University Of Southern California Methods for treating a patient undergoing chemotherapy
US6821953B1 (en) 1999-12-16 2004-11-23 University Of Southern California Methods for treating and preventing damage to mucosal tissue
US6747008B1 (en) 2000-06-19 2004-06-08 University Of Southern California Methods for treating and preventing alopecia
EP1345602B1 (de) * 2000-11-30 2010-07-21 Novodermix International Limited Heilung von wunden
AU2002308522A1 (en) * 2001-05-01 2002-11-11 University Of Southern California Methods for inhibiting tumor cell proliferation
US20090227507A1 (en) * 2008-03-10 2009-09-10 University Of Southern California Angiotensin (1-7) Dosage Forms and Uses Thereof
MX2012010783A (es) 2011-02-02 2012-11-23 Univ Southern California Metodos para tratar ulceras del pie diabetico.
US8557958B1 (en) 2012-06-18 2013-10-15 Tarix Pharmaceuticals Ltd. Compositions and methods for treatment of diabetes
US8633158B1 (en) 2012-10-02 2014-01-21 Tarix Pharmaceuticals Ltd. Angiotensin in treating brain conditions
WO2015002903A1 (en) 2013-07-03 2015-01-08 Arizona Board Of Regents For The University Of Arizona Method for treating cognitive dysfunction
US9333233B2 (en) 2014-02-25 2016-05-10 Tarix Pharmaceuticals Ltd. Methods and compositions for the delayed treatment of stroke
US10183055B2 (en) 2014-07-21 2019-01-22 Arizona Board Of Regents On Behalf Of The University Of Arizona Ang-(1-7) derivative oligopeptides for the treatment of pain and other indications
AU2015294371B2 (en) 2014-07-21 2018-02-01 The Arizona Board Of Regents On Behalf Of The University Of Arizona Ang-(1-7) derivative oligopeptides and methods for using and producing the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5015629A (en) * 1989-06-26 1991-05-14 University Of Southern California Tissue repair

Also Published As

Publication number Publication date
EP0745091A4 (de) 1998-05-20
US5716935A (en) 1998-02-10
WO1995008565A1 (en) 1995-03-30
EP1333034A1 (de) 2003-08-06
JPH09503205A (ja) 1997-03-31
EP1333034B1 (de) 2010-07-14
DE69435301D1 (de) 2010-08-26
ATE473995T1 (de) 2010-07-15
AU697504B2 (en) 1998-10-08
EP0745091A1 (de) 1996-12-04
CA2172494A1 (en) 1995-03-30
AU7836494A (en) 1995-04-10

Similar Documents

Publication Publication Date Title
ZA947337B (en) Use of angiotensin II analogs in tissue repair
ZA947338B (en) Use of angiotensin II and analogs thereof in tissue repair
MX9703609A (es) Uso de fragmentos de angiotensina ii y analogos de la misma para la preparacion de composiciones en la preparacion de tejido.
DE69739440D1 (de) Orale anti-karies zusammensetzung
CA2221730A1 (en) Use of angiotensin ii type 2 receptor agonists in tissue repair
CA2315266A1 (en) Wound healing compositions
JPS5524474B2 (de)
GR3035797T3 (en) Compositions useful for transferring therapeutically active substances into a target cell, and their use in gene therapy
EP0771191A4 (de) Immunologische aktivität der rhamnolipide
JPS6438017A (en) Anticaries and antitartar composition containing zeolitic zinc cation
AU3733495A (en) Liquid antacid compositions containing calcium carbonate and possibly simethicone as active compounds and monobasic potassium phosphate and potassium bicarbonate as buffer
ES2134237T3 (es) Composiciones farmaceuticas que contienen acido ursodesoxicolico.
BR9611472A (pt) Compostos de di-terc-butilfenol contendo enxofre úteis como agentes antiinflamatórios
NO944407D0 (no) Alkoholer som kalium-kanalåpnere og ved behandling av urin-inkontinens
GB0105837D0 (en) Pharmaceutical compositions including alginates
MX9709983A (es) El uso de agonistas receptores tipo 2 de angiotesina ii en la preparacion de composiciones para la preparacion de tejidos.
IL112110A0 (en) Octahydro-1h-isoindoles and pharmaceutical compositions containing them
ZA956989B (en) Methods for bone healing and fracture repair.
ES2049696T3 (es) Utilizacion de una amida como agente espesante y composicion que la contiene.
HUT64964A (en) Method for producing acylamino-alkylidene-hydroxi-biphosphonic acid derivatives as well as one for producing medical preparatives containing said compounds
AU2169088A (en) Thionophosphonates
ATE313615T1 (de) Mittel zur pflegenden behandlung von wasserfesten oberflächen
JPS56122358A (en) Imidazole compound* its manufacture and medicinal composition
DE3824939A1 (de) Neue 2,2-dihalogencyclopropylhydroxyethyltriazole enthaltende antimykotische mittel
SE9601483L (sv) Beredning av komposition